Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasmin for Posterior Vitreous Detachment
NCT00348439Phase 2Terminated
- Sponsor
- Bausch + Lomb
- Start
- Apr 2006
- Primary completion
- Aug 2007
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Vitreomacular traction syndrome (VMT) comparing Plasmin Injection with Vehicle (2 arms). Primary endpoint: Presence of a Grade A Posterior Vitreous Detachment (PVD) at 14 days. Started Apr 2006; status: terminated.
02
Drugs
plasmin
03
Conditions
Vitreomacular traction syndrome (VMT)
Beyond the preview
Go deeper on NCT00348439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00348439.